Work

CHCHD2 and Parkinson's disease

Year: 2015

Type: letter

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(15)00094-0

Authors: Iris E Jansen, Jose M Bras, Suzanne Lesage, Claudia Schulte, J Raphael Gibbs, Mike A Nalls, Alexis Brice, Nicholas W Wood, Huw Morris, John A Hardy, Andrew B Singleton, Thomas Gasser, Peter Heutink, Manu Sharma

Institutions: German Center for Neurodegenerative Diseases, Amsterdam UMC Location Vrije Universiteit Amsterdam, UCL Queen Square Institute of Neurology, University College London, Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau, Université Pierre-et-Marie-Curie, Hertie Institute for Clinical Brain Research, University of Tübingen, National Institutes of Health, National Institute on Aging, National Hospital for Neurology and Neurosurgery

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Wellcome Trust

OpenAlex ID: W3142395575

Cites: 4

Cited by: 64

Related to: 10